Cargando…

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery

OBJECTIVES: The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imperiali, Claudia E., Lopez-Delgado, Juan C., Dastis-Arias, Macarena, Sanchez-Navarro, Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197270/ https://www.ncbi.nlm.nih.gov/pubmed/37360622 http://dx.doi.org/10.1515/almed-2020-0031

Ejemplares similares

Evaluación del papel de diversos biomarcadores en el desarrollo de eventos cardiovasculares adversos mayores en pacientes sometidos a cirugía cardíaca
por: Imperiali, Claudia E., et al.
Publicado: (2020)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Reference interval for immature platelet fraction on Sysmex XN haematology analyser in adult population
por: Imperiali, Claudia E., et al.
Publicado: (2018)

Stability of pH, Blood Gas Partial Pressure, Hemoglobin Oxygen Saturation Fraction, and Lactate Concentration
por: Arbiol-Roca, Ariadna, et al.
Publicado: (2020)

Association of viral load with serum biomakers among COVID-19 cases
por: Shi, Fengjuan, et al.
Publicado: (2020)

Exploring the Molecular Mechanism and Biomakers of Liver Cancer Based on Gene Expression Microarray
por: Liu, Pengfei, et al.
Publicado: (2015)

Renal Function Interferes with Copeptin in Prediction of Major Adverse Cardiac Events in Patients Undergoing Vascular Surgery
por: Schrimpf, Claudia, et al.
Publicado: (2015)

Age-Specific Cardiovascular Risk Factors for Major Adverse Cardiac Events in Patients Undergoing Myocardial Perfusion Imaging
por: Megna, Rosario, et al.
Publicado: (2023)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery
por: Perrone, Marco Alfonso, et al.
Publicado: (2022)

A miRNA- and mRNA-seq-Based Feature Selection Approach for Kidney Cancer Biomakers
por: Kim, Shinuk
Publicado: (2020)

PIG-A gene mutation as a genotoxicity biomaker in polycyclic aromatic hydrocarbon-exposed barbecue workers
por: Cao, Yiyi, et al.
Publicado: (2021)

Association of Major Adverse Cardiovascular Events in Patients With Stroke and Cardiac Wall Motion Abnormalities
por: Kamran, Saadat, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
por: Dadkhah-Tirani, Heidar, et al.
Publicado: (2020)

Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery
por: Larmann, Jan, et al.
Publicado: (2020)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Dailian, et al.
Publicado: (2017)

Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2019)

Postoperative Adverse Cardiovascular Events Associated with Leptin and Adverse Age After Elective Major Non-Cardiac Surgery: An Asian Single-Center Study
por: Gu, Zheng, et al.
Publicado: (2018)

Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis
por: Strickland, Scarlett S, et al.
Publicado: (2023)

Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI
por: Gan, Lijun, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Major adverse cardiovascular events in older emergency department patients presenting with non-cardiac medical complaints
por: Zelis, N., et al.
Publicado: (2022)

Cardiac scoring systems, coronary artery disease and major adverse cardiovascular events: A scoping review
por: Premsagar, Preesha, et al.
Publicado: (2023)

Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas
por: Wang, Hongjun, et al.
Publicado: (2014)

Pre-Frailty Increases the Risk of Adverse Events in Older Patients Undergoing Cardiovascular Surgery
por: Rodrigues, Miguel K., et al.
Publicado: (2017)

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2022)

Sarcoidosis: comprehensive CMR evaluation and major adverse cardiac events
por: Higgins, Angela Y, et al.
Publicado: (2016)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Incidence of postoperative, major, adverse cardiac events in patients undergoing carotid endarterectomy: A single-center, retrospective study
por: Suphathamwit, Aphichat, et al.
Publicado: (2022)

Utility of B-Type Natriuretic Peptide for Predicting Perioperative Cardiovascular Events in Patients Without History of Cardiovascular Disease Undergoing Major Non-Cardiac Surgery
por: Kim, Sung Eun, et al.
Publicado: (2011)

Microvascular reactivity as a predictor of major adverse events in patients with on-pump cardiac surgery
por: Cho, Ah-Reum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73adllc684md2b4rc4aattm349